NCT06661863

Brief Summary

Alveolar ridge preservation (ARP) is a surgical technique that aims to minimize the degree of dimensional changes following extraction. In the healing period after extraction, the alveolar bone (AB) undergoes morphological changes during the remodeling process. The changes become evident immediately after tooth extraction, with greater resorption changes observed during the first two months, and these dimensional changes can be observed 1 year after surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
44mo left

Started Nov 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Nov 2024Dec 2029

First Submitted

Initial submission to the registry

September 3, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

November 15, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2029

Expected
Last Updated

October 28, 2024

Status Verified

October 1, 2024

Enrollment Period

1 month

First QC Date

September 3, 2024

Last Update Submit

October 25, 2024

Conditions

Keywords

Alveolar ResorptionAlveolar processBone SubstitutesAlveolar Bone Grafting

Outcome Measures

Primary Outcomes (1)

  • To evaluate bone formation

    the dimensional bone changes of the preserved at each stage of healing will be analyzed by computer tomography

    The evaluation will occur from enrollment through the end of treatment at 12 months. Assessments will be conducted preoperatively, 7 days post-surgery, as well as at 3, 6, and 12 months following the surgery.

Study Arms (2)

autologous bone

ACTIVE COMPARATOR

An autologous bone graft is defined as a living tissue capable of promoting bone healing by transferring that tissue from a donor area to a recipient area. It has been defined as the "gold standard" for having the capacity for osteogenesis, osteoinduction, osteoconduction and providing good structural support, showing high biocompatibility and low immunogenicity, however, autologous bone is limited and has greater morbidity due to the collection of autologous bone from the donor site, increased surgical time, greater infection, inflammation, pain and bleeding.

Procedure: alveolar ridge preservation with autologous bone

Bioactive glass

EXPERIMENTAL

Bioactive glasses (VB) are a group of synthetic ceramics based on silicates coupled with other minerals. Desirable properties of VB include good biocompatibility, osteoconductivity, antimicrobial activity and a porous structure that promotes vascularization

Procedure: alveolar ridge preservation with bioactive glass

Interventions

Bioactive glass grafted into alveolar preservation.

Bioactive glass

Autologous bone graft in alveolar ridge preservation.

autologous bone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age
  • Patients with indicated tooth extractions
  • Patients who have accepted the conditions of the study

You may not qualify if:

  • Pregnant patients, breastfeeding or using oral contraceptives
  • Smoking patients
  • Patients with uncontrolled systemic diseases
  • History of autoimmune disease
  • Previous traumatic extraction
  • Patients taking bisphosphonates or anticoagulants
  • Patients who are or have undergone chemotherapy and radiotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidadees

Samborondón, Guayas, 09-01-952, Ecuador

Location

MeSH Terms

Conditions

Alveolar Bone Loss

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participants will not know wich biomaterial will be grafted
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study includes 28 patients who have a tooth extraction indicated in reference to g. avila-ortiz et al. 2020. They will be divided into 2 randomized groups, 14 sockets with an infectious process will be preserved with autologous bone and the remaining 14 with 58s bioactive glass
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 3, 2024

First Posted

October 28, 2024

Study Start

November 15, 2024

Primary Completion

December 15, 2024

Study Completion (Estimated)

December 15, 2029

Last Updated

October 28, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations